Phase II Study of Bevacizumab and Preoperative Chemoradiation for Esophageal Adenocarcinoma

Journal of Gastrointestinal Oncology - Hong Kong
doi 10.21037/jgo.2016.08.09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

MA05.01 E6508: Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Unresectable Stage III NS-NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Final Results of a Phase II Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Comparison of Pathologic Stage in Patients Receiving Esophagectomy With and Without Preoperative Chemoradiation Therapy for Esophageal SCC

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Pathologic Complete Response and Dose-Escalation With Preoperative Dose Painting IMRT Chemoradiation in Esophageal Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

A Phase II Study of Endoscopic Resection and Chemoradiation Therapy for Clinical Stage I Esophageal Carcinoma (JCOG 0508): A Report of Radiation Therapy Quality Assurance Program

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients With Unresectable Esophageal and Gastroesophageal Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

Annals of Surgical Oncology
OncologySurgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy